Voyager Therapeutics, Inc.
COMPOSITIONS AND METHODS FOR TREATING HUNTINGTON'S DISEASE
Last updated:
Abstract:
The present disclosure relates to pharmaceutical compositions of adeno-associated viral (AAV) particles encoding siRNA molecules and methods for treating Huntington's Disease (HD).
Status:
Application
Type:
Utility
Filling date:
24 Jul 2020
Issue date:
1 Sep 2022